Non-Vaccine Measles Treatment Identified: UPDATE - Watch Pre-Recorded Q&A with Researchers

Newswise live event on Wednesday April 16th at 1:00 PM EDT featuring Dr. Richard Plemper and Dr. Michael Natchus answering your questions about their recent research [details below]

Released: 16-Apr-2014 5:00 PM EDT
Source Newsroom: Newswise
Contact Information

Available for logged-in reporters only

Citations Live Virtual Press Conference, Wednesday April 16 1 PM EDT; Researchers Develop A New Drug to Combat the Measles

Newswise — A novel antiviral drug may reduce the spread and severity of measles without a vaccination. Dr. Richard Plemper from the Institute for Biomedical Sciences at Georgia State University and Dr. Michael Natchus of the Emory Institute for Drug Discovery (EIDD) will be available to answer questions from the media at a live virtual press conference at 1 PM EDT, Wednesday, April 16th.

Based on animal studies, a novel antiviral drug may protect people infected with the measles from getting sick and prevent them from spreading the virus to others, an international team of researchers says.

Dr. Richard Plemper, Georgia State University will report on the drug, ERDRP-0519, which blocks the replication of the pathogen. You may read more about this research at this news release.

This live event provides reporters with the unique opportunity for a face-to-face encounter with Dr. Plemper. The virtual welcome room for the event will open at 12:00 PM EDT. If this is your first time, we encourage you to join early to address any technical issues you might have.

A limited number of journalists will have access to the room; those who arrive first are guaranteed entry. All participants will be on video (webcam) and visible to one another for improved interaction.

You can participate with a computer, tablet or smart phone.
From your Internet browser click: https://newswiselive.zoom.us/j/7459578068 and follow the simple directions.

If you are using an iPhone or iPad, you will need to download an application by clicking https://itunes.apple.com/us/app/id546505307


Comment/Share